| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial
|
Kim, Dong-Wan
|
|
|
17 |
4 |
p. 452-463
|
artikel
|
| 2 |
ALK inhibitors: plateauing systemic and intracranial activity?
|
Costa, Daniel B
|
|
|
17 |
4 |
p. 404-406
|
artikel
|
| 3 |
Aloe vera, a natural cancer soother?
|
Cathcart, Paul
|
|
|
17 |
4 |
p. 421
|
artikel
|
| 4 |
Amazing Brian
|
Brogan, Caroline
|
|
|
17 |
4 |
p. 422
|
artikel
|
| 5 |
Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials
|
Temel, Jennifer S
|
|
|
17 |
4 |
p. 519-531
|
artikel
|
| 6 |
Apatinib in treatment of refractory gastric cancer
|
Brower, Vicki
|
|
|
17 |
4 |
p. e137
|
artikel
|
| 7 |
A TNM classification for HPV+ oropharyngeal cancer
|
Porceddu, Sandro V
|
|
|
17 |
4 |
p. 403-404
|
artikel
|
| 8 |
Bad Salsa
|
Burki, Talha Khan
|
|
|
17 |
4 |
p. 423
|
artikel
|
| 9 |
Carcinogenicity of some industrial chemicals
|
Grosse, Yann
|
|
|
17 |
4 |
p. 419-420
|
artikel
|
| 10 |
Carfilozomib versus bortezomib for relapsed or refractory myeloma
|
Vogl, Steven E
|
|
|
17 |
4 |
p. e125-e126
|
artikel
|
| 11 |
Carfilozomib versus bortezomib for relapsed or refractory myeloma – Authors' reply
|
Dimopoulos, Meletios A
|
|
|
17 |
4 |
p. e126
|
artikel
|
| 12 |
Challenges for the new Cancer Drugs Fund
|
Littlejohns, Peter
|
|
|
17 |
4 |
p. 416-418
|
artikel
|
| 13 |
Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study
|
Italiano, Antoine
|
|
|
17 |
4 |
p. 532-538
|
artikel
|
| 14 |
Conversations on Dying
|
Kinsey, Caroline A
|
|
|
17 |
4 |
p. 423
|
artikel
|
| 15 |
Correction to Lancet Oncol 2016; 17: 429
|
|
|
|
17 |
4 |
p. e136
|
artikel
|
| 16 |
Cost of unused cancer drugs in the USA
|
Burki, Talha Khan
|
|
|
17 |
4 |
p. e139
|
artikel
|
| 17 |
Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study
|
O'Sullivan, Brian
|
|
|
17 |
4 |
p. 440-451
|
artikel
|
| 18 |
Efficacy and safety of fosaprepitant for the prevention of nausea and emesis during 5 weeks of chemoradiotherapy for cervical cancer (the GAND-emesis study): a multinational, randomised, placebo-controlled, double-blind, phase 3 trial
|
Ruhlmann, Christina H
|
|
|
17 |
4 |
p. 509-518
|
artikel
|
| 19 |
Extent of resection in medulloblastoma: time to reconsider?
|
Hargrave, Darren
|
|
|
17 |
4 |
p. 409-410
|
artikel
|
| 20 |
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
|
Cristofanilli, Massimo
|
|
|
17 |
4 |
p. 425-439
|
artikel
|
| 21 |
Genomic profiling of male breast cancer
|
Burki, Talha Khan
|
|
|
17 |
4 |
p. e141
|
artikel
|
| 22 |
Hyperbaric oxygen therapy for chronic bowel dysfunction after pelvic radiotherapy
|
Wallington, Margaret
|
|
|
17 |
4 |
p. e128
|
artikel
|
| 23 |
Hyperbaric oxygen therapy for chronic bowel dysfunction after pelvic radiotherapy
|
Smart, David
|
|
|
17 |
4 |
p. e128-e129
|
artikel
|
| 24 |
Hyperbaric oxygen therapy for chronic bowel dysfunction after pelvic radiotherapy
|
Bennett, Michael
|
|
|
17 |
4 |
p. e129-e130
|
artikel
|
| 25 |
Hyperbaric oxygen therapy for chronic bowel dysfunction after pelvic radiotherapy
|
Teguh, David N
|
|
|
17 |
4 |
p. e130-e131
|
artikel
|
| 26 |
Hyperbaric oxygen therapy for chronic bowel dysfunction after pelvic radiotherapy
|
Clarke, Richard
|
|
|
17 |
4 |
p. e127-e128
|
artikel
|
| 27 |
Hyperbaric oxygen therapy for chronic bowel dysfunction after pelvic radiotherapy
|
Hampson, Neil B
|
|
|
17 |
4 |
p. e126-e127
|
artikel
|
| 28 |
Hyperbaric oxygen therapy for chronic bowel dysfunction after pelvic radiotherapy – Authors' reply
|
Glover, Mark
|
|
|
17 |
4 |
p. e131-e132
|
artikel
|
| 29 |
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial
|
Aluwini, Shafak
|
|
|
17 |
4 |
p. 464-474
|
artikel
|
| 30 |
Hypofractionation for prostate cancer: a word of caution
|
Bossi, Alberto
|
|
|
17 |
4 |
p. 406-407
|
artikel
|
| 31 |
Let's talk about cancer: communication and patient care
|
Zajanckauskaite, Estera
|
|
|
17 |
4 |
p. 424
|
artikel
|
| 32 |
Metformin for cancer prevention: a reason for optimism
|
Chan, Andrew T
|
|
|
17 |
4 |
p. 407-409
|
artikel
|
| 33 |
Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial
|
Higurashi, Takuma
|
|
|
17 |
4 |
p. 475-483
|
artikel
|
| 34 |
Molecular subgroups of pancreatic cancer
|
Burki, Talha Khan
|
|
|
17 |
4 |
p. e139
|
artikel
|
| 35 |
Multitarget pharmacological inhibition for renal cell carcinoma
|
Granovetter, Michael
|
|
|
17 |
4 |
p. e140
|
artikel
|
| 36 |
Novel trial designs for high-risk myelodysplastic syndromes
|
Alessandrino, Emilio P
|
|
|
17 |
4 |
p. 410-412
|
artikel
|
| 37 |
Overuse of PET to monitor lung or oesophageal cancers
|
Gilbert, Judith A
|
|
|
17 |
4 |
p. e138
|
artikel
|
| 38 |
Paediatric cancer stage in population-based cancer registries: the Toronto consensus principles and guidelines
|
Gupta, Sumit
|
|
|
17 |
4 |
p. e163-e172
|
artikel
|
| 39 |
Paediatric extracranial germ-cell tumours
|
Shaikh, Furqan
|
|
|
17 |
4 |
p. e149-e162
|
artikel
|
| 40 |
Palbociclib: efficacious but predictive biomarkers still needed
|
Cognetti, Francesco
|
|
|
17 |
4 |
p. 402-403
|
artikel
|
| 41 |
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
|
Thompson, Eric M
|
|
|
17 |
4 |
p. 484-495
|
artikel
|
| 42 |
Progress in chemoradiotherapy-induced nausea and vomiting
|
Schwartzberg, Lee
|
|
|
17 |
4 |
p. 412-413
|
artikel
|
| 43 |
Ramucirumab plus docetaxel for urothelial carcinoma
|
Baker, Holly
|
|
|
17 |
4 |
p. e140
|
artikel
|
| 44 |
Reduced intensity transplantation in follicular lymphoma
|
Gilbert, Judith A
|
|
|
17 |
4 |
p. e141
|
artikel
|
| 45 |
Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trial
|
Garcia-Manero, Guillermo
|
|
|
17 |
4 |
p. 496-508
|
artikel
|
| 46 |
Targeting cancer cachexia: we're on the way
|
Muscaritoli, Maurizio
|
|
|
17 |
4 |
p. 414-415
|
artikel
|
| 47 |
The difficulty of comparing drug prices between countries
|
De Block, Maggie
|
|
|
17 |
4 |
p. e125
|
artikel
|
| 48 |
The role of molecular testing in soft tissue sarcoma diagnosis
|
Randall, R Lor
|
|
|
17 |
4 |
p. 415-416
|
artikel
|
| 49 |
Updated Canadian colorectal cancer screening guidelines
|
Tanday, Sanjay
|
|
|
17 |
4 |
p. e137
|
artikel
|
| 50 |
US legislation for direct-to-consumer advertising: paternalism or common sense?
|
The Lancet Oncology,
|
|
|
17 |
4 |
p. 401
|
artikel
|
| 51 |
Watch-and-wait versus surgical resection for patients with rectal cancer
|
Alongi, Filippo
|
|
|
17 |
4 |
p. e133-e134
|
artikel
|
| 52 |
Watch-and-wait versus surgical resection for patients with rectal cancer
|
Saglam, Sezer
|
|
|
17 |
4 |
p. e132
|
artikel
|
| 53 |
Watch-and-wait versus surgical resection for patients with rectal cancer
|
Glynne-Jones, Robert
|
|
|
17 |
4 |
p. e133
|
artikel
|
| 54 |
Watch-and-wait versus surgical resection for patients with rectal cancer – Authors' reply
|
Renehan, Andrew G
|
|
|
17 |
4 |
p. e134-e135
|
artikel
|
| 55 |
Weekly dose-dense chemotherapy for ovarian cancer
|
Tanday, Sanjay
|
|
|
17 |
4 |
p. e138
|
artikel
|
| 56 |
Wernicke-Korsakoff syndrome in patients with cancer: a systematic review
|
Isenberg-Grzeda, Elie
|
|
|
17 |
4 |
p. e142-e148
|
artikel
|
Tijdschrift beschrijving